A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Accumulating evidences underlie the importance of the interplay between environmental and genetic factors in contributing to the risk to develop mental illness. Brain-derived neurotrophic factor (BDNF) and its Tyrosine receptor kinase B (TrkB) receptor play a fundamental contribution to brain development and plastic adaptations to life events. In the present study, the potential for the BDNF/TrkB contribution in increasing vulnerability to negative social experiences was assessed by subjecting TrkB.T1 overexpressing mice to a chronic social defeat model. TrkB.T1 mice overexpress the dominant-negative truncated splice variant of TrkB receptor leading to decreased BDNF signaling. After repeated social defeat, mice were assessed in a longitudinal study for behavioral, physiological, endocrine and immune responses potentially related to psychiatric endophenotypes. TrkB.T1 overexpression corresponded to smaller changes in metabolic parameters such as body weight, food intake, feed efficiency and peripheral ghrelin levels compared with wild-type (wt) littermates following social defeat. Interestingly, 4 weeks after the last defeat, TrkB.T1 overexpressing mice exhibited more consistent social avoidance effects than what observed in wt subjects. Finally, previously unreported effects of TrkB mutations could be observed on lymphoid organ weight and on peripheral immune biomarker levels, such as interleukin-1α and regulated on activation, normal, T-cell expressed, and secreted (RANTES), thus suggesting a systemic role of BDNF signaling in immune function. In conclusion, the present data support a contribution of TrkB to stress vulnerability that, given the established role of TrkB in the response to antidepressant treatment, calls for further studies addressing the link between stress susceptibility and variability in drug efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“A common single gene polymorphism (val66met) interfering with BDNF activitydependent secretion has been described (Egan et al. 2003) and is considered potentially relevant for susceptibility to psychiatric disorders (Gratacos et al. 2007).”
BackgroundKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 3×
“Bilateral intra-NAc infusions of BDNF enhanced susceptibility (Krishnan et al. 2007), whereas a knockdown of BDNF within the ventral tegmental area (VTA) was shown to prevent defeat-induced avoidance (Berton et al. 2006).”
BackgroundEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · cited 4×
“Bilateral intra-NAc infusions of BDNF enhanced susceptibility (Krishnan et al. 2007), whereas a knockdown of BDNF within the ventral tegmental area (VTA) was shown to prevent defeat-induced avoidance (Berton et al. 2006).”
BackgroundInfluentialNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“2009); BDNF has been shown to play a major role in the mood-improving actions of antidepressants (Chen et al. 2001; Nibuya et al. 1995); finally, TrkB receptors need to be present in hippocampal neural progenitor cells for the neurogenic and behavioral actions of antidepressant treatments (Li et al.”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 1×
“…the response to social stress in the mesolimbic dopamine pathway and to its link to sustained hippocampal epigenetic regulation, both of which mediate the long-term neural and behavioral plasticity observed in response to antidepressant treatment (Berton et al. 2006; Tsankova et al. 2006, 2007).”
BackgroundBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · cited 1×
“…the response to social stress in the mesolimbic dopamine pathway and to its link to sustained hippocampal epigenetic regulation, both of which mediate the long-term neural and behavioral plasticity observed in response to antidepressant treatment (Berton et al. 2006; Tsankova et al. 2006, 2007).”
BackgroundNibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896 · cited 3×
“The expression of BDNF in the ventromedial hypothalamus, an important component of the central nervous system (CNS) energy homeostasis circuitry, is reduced after food deprivation (Kernie et al. 2000; Xu et al. 2003); mice with genetically reduced BDNF expression also develop obesity and hyperphagic behavior (Fox & By…”
BackgroundDwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875 · cited 2×
“An impressive amount of data supports this hypothesis: decreased BDNF and TrkB expression has been found in suicide subjects (Dwivedi et al. 2003); a functional single nucleotide BDNF polymorphism in humans has been associated to different mental disorders (Gratacos et al.”
BackgroundAntidepressant-like effect of brain-derived neurotrophic factor (BDNF)
Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00169-4 · Cited by 841
Ghrelin controls hippocampal spine synapse density and memory performance
Diano, S., Farr, S. A., Benoit, S. C., McNay, E. C., da Silva, I., Horvath, B., Gaskin, F. S., Nonaka, N., Jaeger, L. B., Banks, W. A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1656 · Cited by 828 · cited 1×
“…to energy depletion related to decreased food intake (Ariyasu et al. 2001; Kojima et al. 1999) and, interestingly, it can also bind hippocampal receptors (Guan et al. 1997) with profound effects on hippocampal synaptic plasticity (Diano et al. 2006), thus linking metabolic and cognitive systems.”
BackgroundBDNF regulates eating behavior and locomotor activity in mice
Kernie, S. G., Liebl, D. J., & Parada, L. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1290 · Cited by 806 · cited 6×
“…hyperphagic/obese phenotype produced by BDNF deficiency is age-dependent, as its occurrence is reported mostly in mature animals (above 5 months old) (Fox & Byerly 2004; Kernie et al. 2000; Lyons et al. 1999) wherein it has been related to a late reduction in serotonin levels (Rios et al. 2001).”
BackgroundInfluentialSaarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · cited 2×
“Although the impairment in TrkB signaling induced in either TrkB.T1 and BDNF+/− mice (MacQueen et al. 2001; Monteggia et al. 2004; Saarelainen et al. 2003) does not lead to depressive-like phenotypes in basal conditions, TrkB.T1 defeated mice exhibited a very consistent social avoidance.”
BackgroundTrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C.-H., Kernie, S. G., Bassel-Duby, R., & Parada, L. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.023 · Cited by 634 · cited 2×
“…has been shown to play a major role in the mood-improving actions of antidepressants (Chen et al. 2001; Nibuya et al. 1995); finally, TrkB receptors need to be present in hippocampal neural progenitor cells for the neurogenic and behavioral actions of antidepressant treatments (Li et al. 2008).”
BackgroundGatt, J. M., Nemeroff, C. B., Dobson-Stone, C., Paul, R. H., Bryant, R. A., Schofield, P. R., Gordon, E., Kemp, A. H., & Williams, L. M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.143 · Cited by 525 · cited 2×
“…has been associated to different mental disorders (Gratacos et al. 2007) and to vulnerability to the depressogenic effects of early life stress (Gatt et al. 2009); BDNF has been shown to play a major role in the mood-improving actions of antidepressants (Chen et al. 2001; Nibuya et al. 1995);…”
BackgroundPliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509 · cited 2×
“cAMP response element binding protein) (Nibuya et al. 1996; Pliakas et al. 2001).”
BackgroundGratacòs, M., González, J. R., Mercader, J. M., de Cid, R., Urretavizcaya, M., & Estivill, X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.025 · Cited by 428 · cited 2×
“A common single gene polymorphism (val66met) interfering with BDNF activitydependent secretion has been described (Egan et al. 2003) and is considered potentially relevant for susceptibility to psychiatric disorders (Gratacos et al. 2007).”
BackgroundRantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
Self-citationActivation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect
Jeanneteau, F., Garabedian, M. J., & Chao, M. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709102105 · Cited by 215 · cited 1×
“TrkB.T1 has been shown to be upregulated in pathological states such as human Alzheimer’s disease (Ferrer et al. 1999), is involved in pain processing (Renn et al. 2009) and is promoted by stress and various environmental factors (Jeanneteau et al. 2008).”
BackgroundDifferent susceptibility to social defeat stress of BalbC and C57BL6/J mice
Razzoli, M., Carboni, L., Andreoli, M., Ballottari, A., & Arban, R. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.014 · Cited by 147
Self-citationSingle nucleotide polymorphisms related to hpa axis reactivity
DeRijk, R. H. (2009) · NeuroImmunoModulation · doi:10.1159/000216192 · Cited by 140 · cited 1×
“…intercellular messenger modifying hypothalamus–pituitary–adrenal axis activity, as suggested in depressed patients carriers of the Met/Met genotype (Derijk 2009; Schüle et al. 2006) and through its action on stress-related pathways it could exert a peripheral effect on immune function.”
BackgroundChuang, J.-C., Krishnan, V., Yu, H. G., Mason, B., Cui, H., Wilkinson, M. B., Zigman, J. M., Elmquist, J. K., Nestler, E. J., & Lutter, M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.003 · Cited by 114 · cited 3×
“2006), and recent epidemiological evidences support the comorbidity between depressive and metabolic disorders (Beydoun & Wang 2009; Chuang et al., 2010; Goldbacher et al., 2009; Golden et al., 2008; Ma & Xiao, 2009).”
BackgroundResultSchüle, C., Zill, P., Baghai, T. C., Eser, D., Zwanzger, P., Wenig, N., Rupprecht, R., & Bondy, B. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.06.002 · Cited by 94
Cited by
The neurodevelopmental origins of suicidal behavior
Turecki, G., Ernst, C., Jollant, F., Labonté, B., & Mechawar, N. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.008 · Cited by 299
The molecular bases of the suicidal brain
Turecki, G. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3839 · Cited by 281
Stuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 259
Epigenetic signaling in psychiatric disorders: stress and depression
Bagot, R. C., Labonté, B., Peña, C. J., & Nestler, E. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/rbagot · Cited by 171
Rodent Models of Depression: Neurotrophic and Neuroinflammatory Biomarkers
Stepanichev, M., Dygalo, N. N., Grigoryan, G., Shishkina, G. T., & Gulyaeva, N. (2014) · BioMed Research International · doi:10.1155/2014/932757 · Cited by 169
“T1 mice) exhibited smaller changes in body weight and food intake and had more consistent and long-lasting social avoidance than theirwild-type counterparts after social defeat [132].”
Background
Metadata
- Authors
- Razzoli, M., Domenici, E., Carboni, L., Rantamaki, T., Lindholm, J., Castrén, E., & Arban, R.
- Venue
- Genes, Brain and Behavior
- Publisher
- Wiley
- Published
- 2011-02-21
- Volume
- 10
- Issue
- 4
- Pages
- 424-433
- ISSN
- 1601-183X (ISSN-L)
- 1601-1848
- OpenAlex
- W1983295831
- Cited by
- 77
- References
- 26
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.